156
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Does using topical latanoprost affect subfoveal choroidal thickness?

ORCID Icon, , , , &
Pages 370-374 | Received 17 Feb 2019, Accepted 12 Jun 2019, Published online: 02 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandro Bonardi & Claudiu T Supuran. (2019) Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595. Expert Opinion on Therapeutic Patents 29:10, pages 753-759.
Read now

Articles from other publishers (2)

Ihsan Cakir, Seren Pehlivanoglu, Gulay Yalcinkaya & Cigdem Altan. (2022) The Effect of Latanoprost on Choroidal Vascularity Index in Glaucoma and Ocular Hypertension. Journal of Glaucoma 31:12, pages 972-978.
Crossref
Shanna C. Yeung, Jamie Y. Park, Daniel Park, Yuyi You & Peng Yan. (2022) The effect of systemic and topical ophthalmic medications on choroidal thickness: A review. British Journal of Clinical Pharmacology 88:6, pages 2673-2685.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.